Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Clinical trial NCT04465643 · COMPLETED
Trial details
- NCT number
- NCT04465643
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2025-07-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.